Sat.Apr 01, 2023 - Fri.Apr 07, 2023

article thumbnail

Hospitals pledge to protect patient privacy. Almost all their websites leak visitor data like a sieve

STAT

Every hospital in America promises to protect the privacy of its patients and the details of their medical care. And almost every one of them uses sophisticated data tools to track and share the personal information of visitors as soon as they start clicking on their websites. A new study found that 99% of U.S. hospitals employed online data trackers in 2021 that transmitted visitors’ information to a broad network of outside parties, including major technology companies, data brokers, an

Hospitals 363
article thumbnail

A drug just launched for a disease discovered only 10 years ago

PharmaVoice

Pharming just landed an FDA approval for a treatment targeting an ultra-rare immunodeficiency disorder discovered only a decade ago — and it’s already in the hands of patients.

241
241
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Moves Forward with Mail-back Envelopes for Opioid Analgesics Dispensed in Outpatient Settings

LifeProNow

April 03, 2023: “The U.S. FDA announced it is requiring manufacturers of opioid analgesics dispensed in outpatient settings to make prepaid mail-back envelopes available to outpatient pharmacies and other dispensers as an additional opioid analgesic disposal option for patients. “Expanding impactful opioid disposal options, such as mail-back envelopes and in-home disposal, for patients to safely and securely dispose of their unused opioid medications is part of the agency’s comprehensive a

130
130
article thumbnail

5 FDA decisions to watch in the second quarter

BioPharma Dive

By the end of June, the agency could clear a gene therapy for Duchenne muscular dystrophy and two vaccines for RSV, as well as issue a precedent-setting decision on a closely watched ALS drug.

Vaccines 138
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: ‘True disruption’: Mark Cuban’s company will sell brand-name diabetes medicines from J&J

STAT

For the first time, Mark Cuban’s Cost Plus Drug Company is selling medicines made by a large drug manufacturer directly to consumers at a greatly reduced price, the latest sign that the billionaire is trying to make good on his vow to disrupt the opaque pharmaceutical supply chain. Until now, the company has focused on selling generic versions of brand-name medicines.

Diabetes 344
article thumbnail

The silver linings in biotech’s wobbly market

PharmaVoice

A report from accounting firm BDO compares biotech’s tough times with the booming last few years — and points to some silver linings.

246
246

More Trending

article thumbnail

Gene therapy startup Vedere to close two years after launch

BioPharma Dive

The startup, a successor to an eye gene therapy biotech that Novartis bought in 2020, will wind down after preclinical experiments didn’t meet the bar set by its leaders.

131
131
article thumbnail

Opinion: I declined to share my medical data with advertisers at my doctor’s office. One company claimed otherwise

STAT

I care deeply about privacy, and as a professional researcher, I take meticulous notes. During my recent maternity leave, I spent most of my hands-free time trying to figure out why my doctors were trying to give my medical data away to advertisers — even after I opted out.

323
323
article thumbnail

Staff shortages cause slowdowns in booming cell and gene therapy market

PharmaVoice

New reports highlight the need for more targeted biotech education curriculums to shore up a sustainable workforce.

239
239
article thumbnail

Job interview questions for Health Economics and Outcomes Research(HEOR)

LifeProNow

1. What is HEOR, and why is it important in the healthcare industry? HEOR stands for Health Economics and Outcomes Research. It is important in the healthcare industry because it provides insights into the value of healthcare interventions and helps to inform decision-making regarding resource allocation. 2. What are the different types of economic evaluations used in HEOR, and how are they conducted?

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Seagen, Astellas win expanded FDA approval for bladder cancer drug

BioPharma Dive

The first-line approval of Padcev together with Keytruda is viewed as important to expanding the drug’s market, and comes weeks after Pfizer agreed to buy Seagen for $43 billion.

126
126
article thumbnail

1 in 6 people experience infertility worldwide, according to WHO report

STAT

One in six people across the globe face infertility at some point in their lifetime, according to the first new estimates from the World Health Organization in a decade. The prevalence is “staggering,” Pascale Allotey, director of sexual and reproductive health and research at WHO, said at a press conference Monday. The report estimates that 17.8% of adults in high-income countries and 16.5% in low- and middle-income countries experience infertility.

338
338
article thumbnail

5 minutes with — Parexel’s Peyton Howell

PharmaVoice

The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked.

130
130
article thumbnail

Biocon Academy conducts graduation ceremony for 185 students across four programs

Express Pharma

Biocon Academy, a Centre of Excellence for Advanced Learning in Applied Biosciences and a CSR initiative of Biocon held its seventh Graduation Day at its Bengaluru Campus, with 185 students graduating this year. Eight batches across four programs of Biocon Academy namely Biocon KGI Certificate Program in Biosciences, Biocon JSS AHER Certificate Program in Global Regulatory Affairs, Biocon Ramaiah Certificate Program in Quality Control Analytical, and BITS Biocon Certificate Program in Applied In

126
126
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

AbbVie removes two approvals for blood cancer drug Imbruvica

BioPharma Dive

In paring back use of Imbruvica, the drugmaker has become the latest developer to voluntarily withdraw indications for a cancer medicine following a setback in confirmatory testing.

120
120
article thumbnail

STAT+: The biotech scorecard for the second quarter: 24 stock-moving events to watch

STAT

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter: When is “mid-year”? This is not an existential question. Practically speaking, when a drugmaker, let’s say Bridge Bio , tells investors that an important readout of all-cause mortality data from a clinical trial of its heart drug acoramidis is coming “mid-2023,” does that mean the end of June or the beginning of July?

326
326
article thumbnail

All eyes turn to Karuna as it aims for an approval of a would-be blockbuster

PharmaVoice

In the red-hot race for new schizophrenia treatments, Karuna Therapeutics is close to an FDA submission.

148
148
article thumbnail

Eli Lilly Invests Heavily in Debut Mounjaro TV Ad Campaign for Diabetes

PharmExec

Eli Lilly debuts its first Mounjaro TV commercial amid high demand for the diabetes injection, which also shows promise in weight loss applications and outperformed rivals Ozempic and Wegovy in clinical trials.

Diabetes 119
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Clinical in pharmacy: In airport pharmacy the day can start early at 4am!

The Pharmacist

Hala Jawad is a community pharmacist based at Boots, London Gatwick Airport. She talks about the opportunities and challenges in helping the patients visiting an airport pharmacy. How long have you been working in community pharmacy? What attracted you to working in community? I have worked in community pharmacy for around nine years, and I […] The post Clinical in pharmacy: In airport pharmacy the day can start early at 4am!

article thumbnail

Opinion: In a world of synthetic biology, publishing virus DNA sequences may mean perishing

STAT

The wholly synthetic mRNA vaccines for Covid-19 saved nearly 20 million lives in just their first year of use, according to data published in 2022 by The Lancet. That success stands as the most prominent example of the power of synthetic biology, a field whose possibilities have excited me since I first heard the term more than 15 years ago. As scientists gain increasing dexterity in manipulating the basic elements of life, they are designing not only other synthetic vaccines, but also therapies

Vaccines 302
article thumbnail

PulmCrit Blogitorial – Why we will never know how to manage stress hyperglycemia

EMCrit Project

(Blogitorials are short, informal blogs that are written in the spirit of a tweetorial). Stress hyperglycemia is an everyday occurence in the ICU, but we hardly know how to treat it. I've been waiting years for this topic to be clarified… but I've realized that such clarity will probably never be reached. Why? The traditional […] EMCrit Project by Josh Farkas.

119
119
article thumbnail

Freeline cuts more jobs and halts Fabry gene therapy work

BioPharma Dive

The U.K. biotech will lay off 30% of its workforce and focus on an experimental Gaucher disease treatment, five months after an initial restructuring that cut a hemophilia gene therapy.

113
113
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Latest WHO Covid-19 vaccine guidance may decrease future demand

Pharmaceutical Technology

The World Health Organisation (WHO) has revised its recommendations regarding the use of Covid-19 vaccines following a meeting of the agency’s Strategic Advisory Group of Experts on Immunisation (SAGE). The latest guidance applies to the current phase of the pandemic and reflects the impact of the Omicron variant, which has led to high levels of immunity in all age groups through both vaccination efforts and infections across the globe.

Vaccines 111
article thumbnail

Often overlooked, a common infection during pregnancy kickstarts a conversation about newborn screening

STAT

On a spring day in the late 1980s, pediatrician Mark Schleiss was confronted with a difficult case: a months-old infant who had developed pneumonia. While many infants with pneumonia recover, this particular baby had grown so sick he was admitted to the ICU, where he died. The autopsy showed he had disseminated cytomegalovirus, which had caused his pneumonia and then his death.

280
280
article thumbnail

Positive results from hVIVO study of Cidara flu candidate

Pharma Times

Study demonstrated a reduction in viral replication in the upper respiratory tract as well as influenza infection

131
131
article thumbnail

In NEJM, full Pfizer data show RSV vaccine’s protection

BioPharma Dive

Results from two large clinical trials, published in the high-profile medical journal Wednesday, detail the shot’s safety and efficacy against the common respiratory infection.

111
111
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Enanta secures FDA fast track designation for EDP-323 to treat RSV

Pharmaceutical Technology

Enanta Pharmaceuticals has secured the US Food and Drug Administration’s (FDA) fast track designation for EDP-323 to treat respiratory syncytial virus (RSV). In vitro data of EDP-323 showed a significant reduction in RSV replication with picomolar potency in primary human bronchial epithelial cells against RSV A and B. Consistent potency was also observed across a range of RSV clinical isolates in several cell types.

Dosage 110
article thumbnail

STAT+: A devastating skin condition could soon get its first medication, as the frontiers of gene therapy expand

STAT

Wounds have been a constant fact of Aaron Owens’ life. His skin is so fragile that friction that would be trivial to others — rolling over in bed, weight shifting against the seat as the car turns — could scrape off his tissue. He didn’t like being in public sometimes because people would stare at the boy covered in bandages.

274
274
article thumbnail

Cancer and heart disease vaccines ‘ready by end of the decade’

The Guardian - Pharmaceutical Industry

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives ‘A silver lining’: how Covid ushered in a vaccines golden era Millions of lives could be saved by a groundbreaking set of new vaccines for a range of conditions including cancer, experts have said. A leading pharmaceutical firm said it is confident that jabs for cancer, cardiovascular and autoimmune diseases, and other conditions will be ready by 2030.

Vaccines 111
article thumbnail

Vertex, CRISPR finish US filing for gene editing drug approval

BioPharma Dive

The approval application is the first in the U.S. for a CRISPR-based medicine and puts the partners ahead of a rival therapy from Bluebird bio.

122
122
article thumbnail

MHRA fast tracks ADvantage’s immunomodulator for Alzheimer’s disease

Pharmaceutical Technology

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted ADvantage Therapeutics’ immunotherapy AD04 an Innovation Passport for the treatment of Alzheimer’s disease. The designation, under the regulator’s Innovative Licensing and Access Pathway (ILAP), will fast-track a potential route to market for AD04 by providing collaborative opportunities with UK institutes like the National Institute for Health and Care Excellence (NICE).

105
105